Issues. What is a low testosterone? Who needs testosterone therapy? Benefits/adverse effects of testosterone replacement Treatment options

Similar documents
Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent

Testosterone Hormone Replacement Drug Class Prior Authorization Protocol

Jeremiah Murphy, MD Mercy Urology Clinic. October 21, 2017

Insight into male menopause'

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Drug Class Monograph

Testosterone Hormone Replacement Drug Class Prior Authorization Protocol

Secrets of Abang Sado : Effects of testosterone therapy. Azraai Nasruddin

The Testosterone Quandary. Beth Crowder, PhD, APRN

Donald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May Terry s Testosterone

MI Androgen Deficiency Hypogonadism

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Affirming Care of the Transgender Patient

Medication Policy Manual

Associate Professor Geoff Braatvedt

Testosterone Topical/Buccal/Nasal

Androgenes and Antiandrogenes

Natural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone

Original Research Declining testicular function in aging men

SUMMARY and OBJECTIVES. LOW T- I m half the man I used to be. Prevalence of Low-T. Definition of Hypogonadism 9/19/ Million men in the US

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES TESTOSTERON. Generic Brand HICL GCN Exception/Other ROUTE MISCELL.

FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM

TREATMENT OPTIONS FOR MALE HYPOGONADISM

September 17, FDA background documents for the discussion of two major issues in testosterone replacement therapy (TRT):

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

See Important Reminder at the end of this policy for important regulatory and legal information.

Inappropriate Testosterone Billings

M0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:

Adverse effects of anabolic androgenic steroids abuse on gonadal function, glucose homeostasis and cardiovascular function

Robert Perlstein, M.D. Medical Officer. Center for Drug Evaluation and Research. U.S. Food & Drug Administration

Medical Policy Testosterone Therapy

1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride

All About T Testosterone for FTMs. Presented by John Otto, MLIS

Month/Year of Review: September 2013 Date of Last Review: December 2009

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Mens Health Post Puberty. Nayan Patel PharmD

Testosterone Use and Effects

Male Hormone Replacement Therapy. Punita Dhindsa D.O PGY 2

TESTIM (testosterone gel) for topical use, CIII Initial U.S. Approval: 1953

Testosterone Effects in Transmen

Package Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)

XYOSTED (testosterone enanthate) injection, for subcutaneous use CIII Initial US approval: 1953 IMPORTANT SAFETY INFORMATION

Hypogonadism and Testosterone Replacement Therapy

The ICL Insider. Lab Testing: Testosterone. In This Issue. The Debate

Formally known as anabolic steroids or anabolic-androgenic steroids, but they are sometimes called 'roids', 'gear' or 'juice'.

Dr Tarza Jamal Pharmacology Lecture 2

Elements for a public summary

FINCAR Tablets (Finasteride)

PRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)

TESTOVIRON 300 TESTOCYP 200 INJECTABLE PRODUCTS

Female testosterone level chart

Treatment of androgen deficiency in the aging male

TESTOSTERONE gel, for topical use, CIII Initial U.S. Approval: 1953

HIGHLIGHTS OF PRESCRIBING INFORMATION

The Science of. NUTRICULA Longevity Journal

Clinical Policy: Testosterone Reference Number: AZ.CP.PHAR.02 Effective Date: Last Review Date: Line of Business: Arizona Medicaid

Policy. covered: bilateral. alcohol or. Approve. 3. Palliative enanthate injection in. women for. 6 months if. can also sponsive tumor.

TESTOFEN HUMAN CLINICAL TRIAL GENCOR PACIFIC, INC. Copyright 2006 by Gencor Pacific, Inc.

w w w. o p t i m a l h e a l t h m d. c o m Optimal Health & Rejuvenation Center, LLC 2007

Transgender 201: Case Discussion Group

pump. a metered-dose pump that delivers 30 mg of testosterone per twist. Each metered-dose pump is supplied with an applicator.

AndroGel. (testosterone gel) 1% H 3 C

Gynaecomastia. Benign breast conditions information provided by Breast Cancer Care

Chapter 5. General discussion

Use of Performance Enhancing Substances Good Chemistry Gone Bad. Evan M. Klass, M.D., F.A.C.P.

HGH for Sale Natural Anti-Aging Human Growth Hormone

Natural testosterone enhancement

PHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor

*Dr. Mushreq Aziz Tnesh AL-Lamy, **Dr. Asaad Adnan Aziz Al-Safi. *, ** Physical Education College /Al-Qadisiyah University ABSTRACT

ARE FINASTERIDE SIDE EFFECTS PERMANENT

Testosterone Replacement Therapy

If looking for a book Testosterone: Boost Testosterone Naturally - For - Weight Loss, Muscle Building, Libido & Erectile Dysfunction (Testosterone

Nutrition, supplements, and exercise

MALE HORMONE THERAPY OPTIONS

Androgens and Anabolic Steroids Prior Authorization with Quantity Limit Through Preferred Topical Androgen Criteria Program Summary

Arthi Thirumalai 1, Kathryn E. Berkseth 1, John K. Amory 2

Current Data and Considerations Novel Testosterone Formulations

presents with Dr. Paul Savage, MD

Icd-10 low levels of testosterone

Running head: Extremely low testosterone due to RED-S

PRODUCT INFORMATION PRIMOTESTON DEPOT. (testosterone enantate)

Testosterone as a Therapeutic Tool

See 17 for PATIENT COUNSELING INFORMATION and Medication o 50 mg/0.5 ml. Revised: 09/2018 o 100 mg/0.5 ml

2. Testosterone and Aging

PRODUCT INFORMATION. Testosterone Phenylpropionate: Testosterone Phenylpropionate is 3-oxoandrost-4-en-17β-yl

Androgens and Anabolic Steroids Prior Authorization and Quantity Limit Program Summary

Anadrol For Sale Oxymetholone

Anavar For Sale Oxandrolone

NASDAQ: ATRS. Jefferies 2018 Global Healthcare Conference November 15, Robert F. Apple President and Chief Executive Officer

Risks and benefits of testosterone therapy in older men. Matthew Spitzer, Grace Huang, Shehzad Basaria, Thomas G. Travison and Shalender Bhasin

Testim 1% PRODUCT MONOGRAPH. (testosterone gel) Androgens. Paladin Labs Inc. 100 Alexis Nihon Blvd., Suite 600 St. Laurent, Quebec H4M 2P2

Monitoring Hormone Therapy Mark Newman, M.S. President of Precision Analytical Inc.

Elements for a Public Summary. Overview of disease epidemiology

Are Steroids Worth the Risk?

PRODUCT MONOGRAPH ANDROGEL. Testosterone gel. Androgens

Antiduretic Hormone, Growth. Hormone & Anabolic Steroids

Andropause How Relevant?

Natural estrogens estradiol estrone estriol

Cigna Drug and Biologic Coverage Policy

PRODUCT INFORMATION PROVIRON

Transcription:

Male Hypogonadism Jauch Symposium Waterloo, IA May 17, 2013 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships with any proprietary entity producing health care goods or services consumed by or used on patients. Issues What is a low testosterone? Who needs testosterone therapy? Benefits/adverse effects of testosterone replacement Treatment options Hormonal Control of Testosterone Secretion Cleveland Clinic Journal Medicine Page 720 Oct. 2012 CNS Stimulation Hypothalamus FSH Anterior pituitary LH + + Sertoli cells Testis Leydig cells Inhibin GnRH Testosterone 24 Hour Testosterone Secretion Testosterone and Advancing Age Testosterone, ng/ml Young men Old men Testosterone (nmol/l) 177 144 151 158 109 43 Clock time, hours JCEM 56:1278, 1983 Age, years JCEM 86:724, 2001

Total or Free Testosterone Measure total testosterone in most cases Obesity, hypothyroidism, nephrotic syndrome and glucocorticoids affect SHBG Measure free testosterone when SHBG low Normal ranges vary from lab to lab Low or Normal (Hypogonadotropic) Secondary Hypogonadism Low Testosterone Verify (3 AM Samples) Check LH and FSH Elevated (Hypergonadotropic) Primary Hypogonadism Cleveland Clinic Journal Medicine Page 720 Oct. 2012 Disorders Associated With Primary Hypogonadism Klinefelter s Chemotherapy/radiation Trauma Infection Varicocele Secondary Hypogonadism Alcohol abuse Opiates High dose steroids Sleep apnea Hemochromatosis Hyperprolactinemia Anabolic steroids Diabetes When to Order a Testosterone Level A 60 y.o. man with erectile dysfunction after pituitary surgery A tall 20 y.o. man with atrophic testes and gynecomastia A 40 y.o. with fatigue, depression, weight gain and low energy A 40 y.o. man has noted progressive fatigue, low energy, depression and weight gain. His exam is normal, he has 2 children and his wife is pregnant. He wants you to check a serum testosterone.

Specific Symptoms of Androgen Deficiency Delayed sexual development libido Erectile dysfunction Breast enlargement facial hair Hot flashes Infertility, azoospermia Less Specific Symptoms of Androgen Deficiency Low energy Depression Poor concentration/memory muscle mass body fat physical performance Physical Features of Androgen Deficiency Decreased virilization muscle strength body hair Abdominal obesity Gynecomastia Low testicular volume Case Detection Instruments ADAM - androgen deficiency in aging male AMS - aging male symptom scale Both instruments rely on self report Both have low sensitivity and specificity to detect testosterone deficiency when level is <300 Your patient with fatigue and depression has these results Testosterone - 310, 300, 295 LH 3 (1.7-8.6) FSH 2 (1.5-12.4) Prolactin 6 (4-23) TSH 1.4 (0.2-4.2) Does he need testosterone therapy?

This 50 y.o. man has fatigue and low libido. His exam is normal. Testosterone - 130, 180, 190 LH 1 (1.7-8.6) FSH 2 (1.5-12.4) Prolactin 6 (4-23) Free T4 1.2 (0.9-1.5) Secondary Hypogonadism Alcohol abuse Opiates High dose steroids Sleep apnea Hemochromatosis Hyperprolactinemia Anabolic steroids Diabetes Endocrine Society Guidelines Regarding Treatment Treat a man who is hypogonadal based on clinical signs of androgen deficiency and who has a distinctly subnormal testosterone level Outcomes of Testosterone Therapy in Hypogonadal Men Virilization muscle strength fat free mass bone density PSA prostate volume No placebo controlled trials looking at effect of testosterone on depression, cognition, fracture, QOL or CV outcome in young hypogonadal men Some trials show improvement in libido but not erectile dysfunction Relationship between low testosterone and increase in overall mortality not established Testosterone Replacement Options Oral Buccal Transdermal Injectable Aim for mid normal range

Serum Levels During Chronic Administration of Testosterone Serum testosterone, ng/ml Injection Patch Gel 200 mg 100 mg Time, days 100 mg 200 mg JCEM 51:1335, 1999 Testosterone Gel Androgel, testim, fortesta, axiron Daily administration Levels reach mid normal range in 1 month Levels remain stable for 24 hours Injectable Testosterone Enanthate/cypionate Gradual release 100-300 mg q 2-3 weeks Less expensive Other Preparations Buccal tablet - twice daily Testosterone pellet - subdermal q 3-6 months Human chorionic gonadotropin - for fertility usually Adverse Effects of Testosterone hematocrit HDL PSA prostate growth Worsen sleep apnea Gynecomastia Heart disease? While on Testosterone Therapy Monitor PSA Prostate size Hematocrit LFT s Lipids

Don t Use Testosterone Hematocrit >50% Untreated sleep apnea BPH Congestive heart failure Desire for fertility Breast cancer Prostate cancer A 75 y.o. man complains of fatigue and low libido. He is active and takes no medications. At a recent visit his exam is normal and his testosterone is 210 (200-800). Percentage of Men with Hypogonadism Percentage Testosterone Free T index Age Decade JCEM 86:724, 2001 Testosterone Deficiency in Elderly Men With unequivocally low testosterone (<200) do same evaluation as in younger men Target should be 300-400 ng/dl Digital rectal exam before and after starting testosterone Urology if prostate size increases or nodule develops Durability of androgen effect questionable - 274 frail elderly men treated for 6 months. Effect on muscle mass and strength not maintained when treatment stopped. 209 men with low testosterone and limited mobility had increased CV adverse events NEJM 363:109, 2010 Take Home Points Don t screen for testosterone deficiency in the general population Don t use case finding instruments for detection of testosterone deficiency Measure testosterone in appropriate clinical settings Don t test in hospitalized or chronically ill

Take Home Points With treatment aim to restore testosterone to normal range Role of testosterone in treating hypogonadism in those >60 is uncertain Testosterone therapy should not replace healthy lifestyle changes References McGill J, Shoskes D, Sabanegh E. Androgen deficiency in older men: Indications, advantages and pitfalls of testosterone replacement therapy. Cleve Clin J Med 79:797, 2012. Pantalone K, Faiman C. Male hypogonadism: More than just a low testosterone. Cleve Clin J Med 79:717, 2012. Basaria S, Coviello A, Travison T, et al. Adverse events associated with testosterone administration. NEJM 363:109, 2010. Endocrine Society Clinical Practice Guideline. Testosterone therapy in adult men with androgen deficiency syndromes. JCEM 95:2536, 2010.